Eight-analyte biomarker panel
Biomarker1 paper1 finding
- Humans1
Interventions
1Empagliflozin
no changein humans1
1 study
Empagliflozin
no changein humans1
Empagliflozin has no effect on eight-analyte biomarker panel in humans.
HumansNon-valvular atrial fibrillation; empagliflozin users (n = 98) compared with dapagliflozin users (n = 70)
Endothelial and oxidative biomarker profiles in atrial fibrillation according to SGLT2 inhibitor exposure: a cross-sectional study · Research Square · 7 Oct 2026 · Preprint